Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Shares Issued (2016 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Shares Issued for 12 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued rose 482.77% year-over-year to $1.8 million, compared with a TTM value of $2.8 million through Sep 2025, up 122.38%, and an annual FY2024 reading of $1.3 million, down 24.18% over the prior year.
  • Shares Issued was $1.8 million for Q3 2025 at Fennec Pharmaceuticals, up from -$185000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.8 million in Q3 2025 and bottomed at -$470000.0 in Q3 2024.
  • Average Shares Issued over 4 years is $395333.3, with a median of $347000.0 recorded in 2024.
  • The sharpest move saw Shares Issued surged 1320.0% in 2023, then tumbled 318.6% in 2024.
  • Year by year, Shares Issued stood at $679000.0 in 2022, then rose by 10.01% to $747000.0 in 2023, then increased by 6.69% to $797000.0 in 2024, then skyrocketed by 125.72% to $1.8 million in 2025.
  • Business Quant data shows Shares Issued for FENC at $1.8 million in Q3 2025, -$185000.0 in Q2 2025, and $371000.0 in Q1 2025.